---
title: "TUS-PHARMA: The 58.607 million shares held by the controlling shareholder are subject to judicial auction, and the company's control will change. TUS-PHARMA announced that on August 6, 2025, the company received the \"Execution Ruling\" from the Beijing Financial Court delivered by Hunan Sailoxian [Jing 74 Zhi 1019]"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/252236362.md"
description: "TUS-PHARMA announced that its controlling shareholder, Qidi Kefu, will have 58.607 million shares of stock judicially auctioned and transferred to Hunan Sailoxian. After this equity change, Qidi Kefu will no longer hold any shares in the company, and its concerted party, Huaqing Investment, will also see a significant decrease in its shareholding ratio. Hunan Sailoxian will hold 24.47% of the company's shares, and this change will lead to a shift in the company's control, affecting the equity structure and corporate governance"
datetime: "2025-08-08T12:29:43.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/252236362.md)
  - [en](https://longbridge.com/en/news/252236362.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/252236362.md)
generator: "portal-rs"
---

# TUS-PHARMA: The 58.607 million shares held by the controlling shareholder are subject to judicial auction, and the company's control will change. TUS-PHARMA announced that on August 6, 2025, the company received the "Execution Ruling" from the Beijing Financial Court delivered by Hunan Sailoxian [Jing 74 Zhi 1019]

The ruling transfers 58.607 million shares of TUS-PHARMA held by Qidi Kefu to the buyer Hunan Sailoxian. After this equity change, Qidi Kefu will no longer hold shares in the company, and its concerted actor, Huaqing Investment, will see its shareholding in the company decrease from 63.1514 million shares to 4.5445 million shares, reducing its total shareholding ratio from 26.37% to 1.90%. Hunan Sailoxian will hold 58.607 million shares of the company, accounting for 24.47% of the total share capital. This equity change still needs to complete the transfer and other legal procedures. This equity change does not trigger a tender offer. After the completion of this equity change, Hunan Sailoxian will hold 24.47% of the company's shares. This equity change will lead to a change in the company's control, significantly impacting the company's equity structure and governance

### Related Stocks

- [000590.CN](https://longbridge.com/en/quote/000590.CN.md)

## Related News & Research

- [How Refrigerator Cyberattack Will Impact Colruyt Group (ENXTBR:COLR) Investors](https://longbridge.com/en/news/305581525.md)
- [Fed 'has some work to do on inflation,' KC Fed chief says](https://longbridge.com/en/news/305579295.md)
- [How to recognize the signs of a Bitcoin market peak](https://longbridge.com/en/news/305581088.md)
- [Is Stronger Earnings Altering The Investment Case For AEM Holdings Stock (SGX:AWX)?](https://longbridge.com/en/news/305580444.md)
- [Does Three Segment Reorganization Change The Bull Case For General Mills (GIS)?](https://longbridge.com/en/news/305581557.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**